Evidence map›Paper›PMID 29188996›Full record

ArticleBioconjugate chemistry2018

a-Factor Analogues Containing Alkyne- and Azide-Functionalized Isoprenoids Are Efficiently Enzymatically Processed and Retain Wild-Type Bioactivity.

Veronica Diaz-Rodriguez, Erh-Ting Hsu, Elena Ganusova, Elena R Werst, Jeffrey M Becker, Christine A Hrycyna, Mark D Distefano

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. a-Factor: a chemical biology tool for the study of protein prenylation.Current topics in peptide & protein research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Veronica Diaz-RodriguezDepartment of Chemistry, University of Minnesota , 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States.
Erh-Ting HsuDepartment of Chemistry, Purdue University , 560 Oval Drive, West Lafayette, Indiana 47907, United States.
Elena GanusovaDepartment of Microbiology, University of Tennessee , Circle Park Drive, Knoxville, Tennessee 37996, United States.
Elena R WerstDepartment of Chemistry, University of Minnesota , 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States.
Jeffrey M BeckerDepartment of Microbiology, University of Tennessee , Circle Park Drive, Knoxville, Tennessee 37996, United States.
Christine A HrycynaDepartment of Chemistry, Purdue University , 560 Oval Drive, West Lafayette, Indiana 47907, United States.ORCID 0000-0001-9881-2063
Mark D DistefanoDepartment of Chemistry, University of Minnesota , 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States.ORCID 0000-0002-2872-0259
University of Minnesota · USCircle Park · USPurdue University West Lafayette · US

Funding

TRAINING FOR FUTURE BIOTECHNOLOGY DEVELOPMENTT32GM008347 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHMIDT-DANNERT, CLAUDIA · 1990 to 2021
$11.0M
PEPTIDE/CELL INTERACTIONS IN SACCHAROMYCES CEREVISIAER01GM022087 · NIGMS · UNIVERSITY OF TENNESSEE KNOXVILLE · PI BECKER, JEFFREY M., NAIDER, FRED R · 1985 to 2011
$4.9M
Chemistry-Biology Interface Training GrantT32GM008700 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1999 to 2018
$4.0M
Enzymatic Protein LabelingR01GM084152 · NIGMS · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D · 2010 to 2019
$2.6M
Structure, Function and Conformational Dynamics of the Ste14p MethyltransferaseR01GM106082 · NIGMS · PURDUE UNIVERSITY · PI HRYCYNA, CHRISTINE A · 2013 to 2017
$1.4M
Peptide-Cell Interactions in Saccharomyces cerevisiaeR56GM022087 · NIGMS · UNIVERSITY OF TENNESSEE KNOXVILLE · PI BECKER, JEFFREY M. · 2007 to 2007
$294k
NIGMS NIH HHS R01 GM022087NIGMS NIH HHS R01 GM084152NIGMS NIH HHS R01 GM106082NIGMS NIH HHS R56 GM022087NIGMS NIH HHS T32 GM008347NIGMS NIH HHS T32 GM008700
6 · The paper itself

Abstract

Protein prenylation is a post-translational modification that involves the addition of one or two isoprenoid groups to the C-terminus of selected proteins using either farnesyl diphosphate or geranylgeranyl diphosphate. Three crucial enzymatic steps are involved in the processing of prenylated proteins to yield the final mature product. The farnesylated dodecapeptide, a-factor, is particularly useful for studies of protein prenylation because it requires the identical three-step process to generate the same C-terminal farnesylated cysteine methyl ester substructure present in larger farnesylated proteins. Recently, several groups have developed isoprenoid analogs bearing azide and alkyne groups that can be used in metabolic labeling experiments. Those compounds have proven useful for profiling prenylated proteins and also show great promise as tools to study how the levels of prenylated proteins vary in different disease models. Herein, we describe the preparation and use of prenylated a-factor analogs, and precursor peptides, to investigate two key questions. First, a-factor analogues containing modified isoprenoids were prepared to evaluate whether the non-natural lipid group interferes with the biological activity of the a-factor. Second, a-factor-derived precursor peptides were synthesized to evaluate whether they can be efficiently processed by the yeast proteases Rce1 and Ste24 as well as the yeast methyltransferase Ste14 to yield mature a-factor analogues. Taken together, the results reported here indicate that metabolic labeling experiments with azide- and alkyne-functionalized isoprenoids can yield prenylated products that are fully processed and biologically functional. Overall, these observations suggest that the isoprenoids studied here that incorporate bio-orthogonal functionality can be used in metabolic labeling experiments without concern that they will induce undesired physiological changes that may complicate data interpretation.

Indexed as

AlkynesAzidesCell LineMating FactorProtein PrenylationProteolysisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTerpenesAlkynesAzidesMating FactorSaccharomyces cerevisiae ProteinsTerpenes

Identifiers

PMID29188996
PMCPMC5824361
OpenAlexW2774881317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.